Literature DB >> 23253236

T-helper 17 cells: the driving force of psoriasis and psoriatic arthritis.

In Seol Yoo1, Jeung Hoon Lee, Seung Tak Song, Jin Hyun Kim, Hyun Ji Lee, Seong Wook Kang.   

Abstract

AIM: There is growing evidence that two recently recognized, unique subsets of CD4(+) T-cells, T-helper 17 cells (Th17) and CD4(+) CD25(+) regulatory T-cells (Treg), may play important roles in the pathogenesis of psoriasis. This study sought to investigate the relationship between Th17 cells and psoriasis or psoriatic arthritis (PsA).
METHODS: Peripheral blood CD4(+) T-cells were isolated from 47 patients with psoriasis and 47 controls, and were cultured under various stimulatory conditions. The Th17 cells and regulatory Treg cells were detected by flow cytometry. Plasma interleukin (IL)-17 was measured by enzyme-linked immunosorbent assay.
RESULTS: The proportion of Th17 and Treg cells from peripheral blood mononuclear cells showed no difference between patients with psoriasis and controls. However, psoriasis and PsA patients demonstrated a higher proportion of induced Th17 cells, which was correlated with psoriasis area severity index score. The level of plasma IL-17A in psoriasis was higher than that in controls.
CONCLUSION: Th17 cells may play important roles in the pathogenesis of psoriasis and psoriatic arthritis.
© 2012 The Authors International Journal of Rheumatic Diseases © 2012 Asia Pacific League of Associations for Rheumatology and Wiley Publishing Asia Pty Ltd.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23253236     DOI: 10.1111/j.1756-185X.2012.01813.x

Source DB:  PubMed          Journal:  Int J Rheum Dis        ISSN: 1756-1841            Impact factor:   2.454


  8 in total

1.  Psoriasis in Patients with Metabolic Syndrome or Type 2 Diabetes Mellitus: Treatment Challenges.

Authors:  Sukhmani Pannu; David Rosmarin
Journal:  Am J Clin Dermatol       Date:  2021-02-15       Impact factor: 7.403

2.  Skin-infiltrating, interleukin-22-producing T cells differentiate pediatric psoriasis from adult psoriasis.

Authors:  Kelly M Cordoro; Maria Hitraya-Low; Keyon Taravati; Priscila Munoz Sandoval; Esther Kim; Jeffrey Sugarman; Mariela L Pauli; Wilson Liao; Michael D Rosenblum
Journal:  J Am Acad Dermatol       Date:  2017-06-16       Impact factor: 15.487

3.  Comparison of Cytokine Expression in Paediatric and Adult Psoriatic Skin.

Authors:  Jin Cheol Kim; So Min Kim; Byung Woo Soh; Eun-So Lee
Journal:  Acta Derm Venereol       Date:  2020-02-25       Impact factor: 3.875

4.  Endogenous n-3 polyunsaturated fatty acids protect against imiquimod-induced psoriasis-like inflammation via the IL-17/IL-23 axis.

Authors:  Si Qin; Ju Wen; Xiao-Chun Bai; Tian-Yu Chen; Rong-Chang Zheng; Gui-Bin Zhou; Jing Ma; Jie-Ying Feng; Bi-Ling Zhong; Yi-Ming Li
Journal:  Mol Med Rep       Date:  2014-04-09       Impact factor: 2.952

Review 5.  The Th17 axis in psoriatic disease: pathogenetic and therapeutic implications.

Authors:  Beatrice Marinoni; Angela Ceribelli; Marco S Massarotti; Carlo Selmi
Journal:  Auto Immun Highlights       Date:  2014-01-22

6.  Interleukin-17+CD8+ T cells are enriched in the joints of patients with psoriatic arthritis and correlate with disease activity and joint damage progression.

Authors:  Bina Menon; Nicola J Gullick; Gina J Walter; Megha Rajasekhar; Toby Garrood; Hayley G Evans; Leonie S Taams; Bruce W Kirkham
Journal:  Arthritis Rheumatol       Date:  2014-05       Impact factor: 10.995

7.  Probiotic Lactobacillus sakei proBio-65 Extract Ameliorates the Severity of Imiquimod Induced Psoriasis-Like Skin Inflammation in a Mouse Model.

Authors:  Irfan A Rather; Vivek K Bajpai; Yun Suk Huh; Young-Kyu Han; Eijaz A Bhat; Jeongheui Lim; Woon K Paek; Yong-Ha Park
Journal:  Front Microbiol       Date:  2018-05-17       Impact factor: 5.640

8.  Lactobacillus pentosus GMNL-77 inhibits skin lesions in imiquimod-induced psoriasis-like mice.

Authors:  Yi-Hsing Chen; Chieh-Shan Wu; Ya-Husan Chao; Chi-Chen Lin; Hui-Yun Tsai; Yi-Rong Li; Yi-Zhen Chen; Wan-Hua Tsai; Yu-Kuo Chen
Journal:  J Food Drug Anal       Date:  2016-08-05       Impact factor: 6.157

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.